Meridian Bioscience Inc (VIVO) 19.15 $VIVO
6.73% Edge For 5 Healthcare Lowest-Priced, High-Yield January Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Thu Feb 05, 6:43PM CST
SNN: 35.82 (-0.28), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), SNY: 49.42 (+0.82), PDLI: 7.28 (+0.03)
10 Hardy Healthcare Dividend Dogs Hit 20% Mean January Upsides
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 7:53PM CST
KND: 19.68 (-0.38), BDX: 143.71 (+0.72), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), MR: 27.19 (+0.15), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), TEVA: 56.77 (-0.58), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
10 Mid-Cap Companies To Consider For Your Dividend Growth Portfolio
On Base - at Seeking Alpha - Wed Jan 28, 6:14PM CST
SON: 46.65 (-0.79), VIVO: 19.15 (+0.16), NWN: 47.60 (-0.26), TCRD: 11.75 (+0.23), AVA: 33.95 (-0.52), VVC: 44.75 (-0.59), BAH: 30.16 (+0.18), THG: 72.27 (-0.55), MCY: 53.93 (+0.05), ERIE: 90.87 (-0.18)
Meridian Bioscience: In-line Earnings, Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:10AM CST
Diagnostic test-kit maker Meridian Bioscience, Inc. (VIVO) reported first-quarter fiscal 2015 (ended Dec 31, 2014) EPS of 19 cents, up 6% on a year-over-year basis and inline with the Zacks Consensus Estimate
VIVO: 19.15 (+0.16), AXDX: 22.86 (-0.33), IDXX: 159.08 (+1.72), VRML: 2.08 (+0.12)
Downtrend Call Working As Meridian Bioscience Stock Falls 11.6% (VIVO)
Comtex SmarTrend(R) - Thu Jan 22, 5:08PM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 5 months, Meridian Bioscience has returned 11.55% as of today's recent price of $17.34.
VIVO: 19.15 (+0.16)
Meridian reaffirms FY2015 guidance after FQ1 results
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:59AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience meets 1Q profit forecasts
Automated Insights - Thu Jan 22, 7:18AM CST
CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Thursday reported fiscal first-quarter earnings of $7.9 million.
VIVO: 19.15 (+0.16)
Meridian Bioscience EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:04AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:04AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
Business Wire - Thu Jan 22, 7:00AM CST
Meridian Bioscience, Inc. (NASDAQ: VIVO):
VIVO: 19.15 (+0.16)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 4:30PM CST
FITB: 19.26 (+0.07), APH: 56.39 (+0.39), VIVO: 19.15 (+0.16), NTRS: 70.08 (-0.51), USB: 45.07 (-0.05), UNH: 109.44 (-0.40), AMTD: 35.84 (-0.22), ASML: 104.48 (+0.44)
5 Stocks Set to Soar on Bullish Earnings: Netflix, Cree and More
at The Street - Tue Jan 20, 6:00AM CST
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
NFLX: 466.10 (+9.37), KMI: 41.97 (+0.21), VIVO: 19.15 (+0.16), JNS: 17.38 (+0.24), CREE: 37.51 (+0.08)
Meridian Bioscience Down 15.4% Since SmarTrend Downtrend Call (VIVO)
Comtex SmarTrend(R) - Thu Jan 15, 11:15AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 5 months, Meridian Bioscience has returned 15.38% as of today's recent price of $16.59.
VIVO: 19.15 (+0.16)
Meridian inaugurates new office in Beijing, China in support of its IVD customers
M2 - Mon Jan 12, 7:04AM CST
Life science company Meridian Bioscience (NasdaqGS:VIVO) reported on Friday the opening of a new office in the heart of the central business district (CBD) of Beijing, China.
VIVO: 19.15 (+0.16)
Meridian Opens a New Office in Beijing, China
Business Wire - Fri Jan 09, 11:18AM CST
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS) has opened a new office in Beijing, China. The office is located on Chang-An Avenue (close to Tiananmen Square and government offices) on the 15th floor in the New China Life Insurance (NCI) Tower Center, in the heart of the central business district (CBD) of Beijing.
VIVO: 19.15 (+0.16), LFC: 61.69 (+0.65)
15.5% Return Seen to Date on SmarTrend Meridian Bioscience Call (VIVO)
Comtex SmarTrend(R) - Thu Jan 08, 9:41AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 4 months, Meridian Bioscience has returned 15.53% as of today's recent price of $16.56.
VIVO: 19.15 (+0.16)
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides
Fredrik Arnold - at Seeking Alpha - Sun Jan 04, 1:11AM CST
KND: 19.68 (-0.38), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), HLS: 45.01 (+0.30), MR: 27.19 (+0.15), SEM: 14.32 (+0.11), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), TRIB: 17.30 (-0.12), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
Downgrade Alert for Meridian Bioscience (VIVO)
Comtex SmarTrend(R) - Fri Jan 02, 6:53AM CST
Meridian Bioscience (NASDAQ:VIVO) was downgraded from Market Perform to Underperform at Raymond James today. The stock closed yesterday at $16.46 on volume of 325,000 shares, above average daily volume of 308,000. Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The Company also offers bio- pharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.
VIVO: 19.15 (+0.16)
Meridian Bioscience Shares Down 15.4% Since SmarTrend's Sell Call (VIVO)
Comtex SmarTrend(R) - Wed Dec 24, 9:59AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 4 months, Meridian Bioscience has returned 15.43% as of today's recent price of $16.58.
VIVO: 19.15 (+0.16)
6.73% Edge For 5 Healthcare Lowest-Priced, High-Yield January Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Thu Feb 05, 6:43PM CST
SNN: 35.82 (-0.28), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), SNY: 49.42 (+0.82), PDLI: 7.28 (+0.03)
10 Hardy Healthcare Dividend Dogs Hit 20% Mean January Upsides
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 7:53PM CST
KND: 19.68 (-0.38), BDX: 143.71 (+0.72), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), MR: 27.19 (+0.15), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), TEVA: 56.77 (-0.58), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
10 Mid-Cap Companies To Consider For Your Dividend Growth Portfolio
On Base - at Seeking Alpha - Wed Jan 28, 6:14PM CST
SON: 46.65 (-0.79), VIVO: 19.15 (+0.16), NWN: 47.60 (-0.26), TCRD: 11.75 (+0.23), AVA: 33.95 (-0.52), VVC: 44.75 (-0.59), BAH: 30.16 (+0.18), THG: 72.27 (-0.55), MCY: 53.93 (+0.05), ERIE: 90.87 (-0.18)
Meridian Bioscience: In-line Earnings, Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:10AM CST
Diagnostic test-kit maker Meridian Bioscience, Inc. (VIVO) reported first-quarter fiscal 2015 (ended Dec 31, 2014) EPS of 19 cents, up 6% on a year-over-year basis and inline with the Zacks Consensus Estimate
VIVO: 19.15 (+0.16), AXDX: 22.86 (-0.33), IDXX: 159.08 (+1.72), VRML: 2.08 (+0.12)
Downtrend Call Working As Meridian Bioscience Stock Falls 11.6% (VIVO)
Comtex SmarTrend(R) - Thu Jan 22, 5:08PM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 5 months, Meridian Bioscience has returned 11.55% as of today's recent price of $17.34.
VIVO: 19.15 (+0.16)
Meridian reaffirms FY2015 guidance after FQ1 results
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:59AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience meets 1Q profit forecasts
Automated Insights - Thu Jan 22, 7:18AM CST
CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Thursday reported fiscal first-quarter earnings of $7.9 million.
VIVO: 19.15 (+0.16)
Meridian Bioscience EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:04AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:04AM CST
VIVO: 19.15 (+0.16)
Meridian Bioscience Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
Business Wire - Thu Jan 22, 7:00AM CST
Meridian Bioscience, Inc. (NASDAQ: VIVO):
VIVO: 19.15 (+0.16)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 4:30PM CST
FITB: 19.26 (+0.07), APH: 56.39 (+0.39), VIVO: 19.15 (+0.16), NTRS: 70.08 (-0.51), USB: 45.07 (-0.05), UNH: 109.44 (-0.40), AMTD: 35.84 (-0.22), ASML: 104.48 (+0.44)
5 Stocks Set to Soar on Bullish Earnings: Netflix, Cree and More
at The Street - Tue Jan 20, 6:00AM CST
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
NFLX: 466.10 (+9.37), KMI: 41.97 (+0.21), VIVO: 19.15 (+0.16), JNS: 17.38 (+0.24), CREE: 37.51 (+0.08)
Meridian Bioscience Down 15.4% Since SmarTrend Downtrend Call (VIVO)
Comtex SmarTrend(R) - Thu Jan 15, 11:15AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 5 months, Meridian Bioscience has returned 15.38% as of today's recent price of $16.59.
VIVO: 19.15 (+0.16)
Meridian inaugurates new office in Beijing, China in support of its IVD customers
M2 - Mon Jan 12, 7:04AM CST
Life science company Meridian Bioscience (NasdaqGS:VIVO) reported on Friday the opening of a new office in the heart of the central business district (CBD) of Beijing, China.
VIVO: 19.15 (+0.16)
Meridian Opens a New Office in Beijing, China
Business Wire - Fri Jan 09, 11:18AM CST
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS) has opened a new office in Beijing, China. The office is located on Chang-An Avenue (close to Tiananmen Square and government offices) on the 15th floor in the New China Life Insurance (NCI) Tower Center, in the heart of the central business district (CBD) of Beijing.
VIVO: 19.15 (+0.16), LFC: 61.69 (+0.65)
15.5% Return Seen to Date on SmarTrend Meridian Bioscience Call (VIVO)
Comtex SmarTrend(R) - Thu Jan 08, 9:41AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 4 months, Meridian Bioscience has returned 15.53% as of today's recent price of $16.56.
VIVO: 19.15 (+0.16)
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides
Fredrik Arnold - at Seeking Alpha - Sun Jan 04, 1:11AM CST
KND: 19.68 (-0.38), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), HLS: 45.01 (+0.30), MR: 27.19 (+0.15), SEM: 14.32 (+0.11), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), TRIB: 17.30 (-0.12), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
Downgrade Alert for Meridian Bioscience (VIVO)
Comtex SmarTrend(R) - Fri Jan 02, 6:53AM CST
Meridian Bioscience (NASDAQ:VIVO) was downgraded from Market Perform to Underperform at Raymond James today. The stock closed yesterday at $16.46 on volume of 325,000 shares, above average daily volume of 308,000. Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The Company also offers bio- pharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.
VIVO: 19.15 (+0.16)
Meridian Bioscience Shares Down 15.4% Since SmarTrend's Sell Call (VIVO)
Comtex SmarTrend(R) - Wed Dec 24, 9:59AM CST
SmarTrend identified a Downtrend for Meridian Bioscience (NASDAQ:VIVO) on August 27th, 2014 at $19.61. In approximately 4 months, Meridian Bioscience has returned 15.43% as of today's recent price of $16.58.
VIVO: 19.15 (+0.16)
